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OBJECTIVE: To analyze the flow of retrobulbar vessels in retinoblastoma by color Doppler imaging.
METHODS: A prospective study of monocular retinoblastoma treated by enucleation between 2010 and 2014.
The examination comprised fundoscopy, magnetic resonance imaging, ultrasonography and color Doppler
imaging. The peak blood velocities in the central retinal artery and central retinal vein of tumor-containing eyes
(tuCRAv and tuCRVv, respectively) were assessed. The velocities were compared with those for normal eyes
(nlCRAv and nlCRVv) and correlated with clinical and pathological findings. Tumor dimensions in the
pathological sections were compared with those in magnetic resonance imaging and ultrasonography and were
correlated with tuCRAv and tuCRVv. In tumor-containing eyes, the resistivity index in the central retinal artery
and the pulse index in the central retinal vein were studied in relation to all variables.
RESULTS: Eighteen patients were included. Comparisons between tuCRAv and nlCRAv and between tuCRVv and
nlCRVv revealed higher velocities in tumor-containing eyes (po0.001 for both), with a greater effect in the central
retinal artery than in the central retinal vein (p=0.024). Magnetic resonance imaging and ultrasonography
measurements were as reliable as pathology assessments (p=0.675 and p=0.375, respectively). A positive relationship
was found between tuCRAv and the tumor volume (p=0.027). The pulse index in the central retinal vein was lower
in male patients (p=0.017) and in eyes with optic nerve invasion (p=0.0088).
CONCLUSIONS: TuCRAv and tuCRVv are higher in tumor-containing eyes than in normal eyes. Magnetic
resonance imaging and ultrasonography measurements are reliable. The tumor volume is correlated with a
higher tuCRAv and a reduced pulse in the central retinal vein is correlated with male sex and optic nerve
invasion.
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’ INTRODUCTION
Retinoblastoma is a highly malignant ocular neoplasm that
tends to progress to optic disc invasion (1), which suggests
a poor prognosis for the patient (2). The diagnosis of nerve
invasion at patient presentation is important for prognos-
tication and management (3). Magnetic resonance imaging
(MRI) is used to confirm the presence of a tumor inside the
eye, to determine the extent of the tumor within the optic
nerve and the brain as well as to detect associated primary
intracranial pinealoma (4).
Although MRI is the gold standard for detecting nerve
invasion and is recommended for every child suspected of
harboring a retinoblastoma (5), it can be ineffective for this
purpose. This problem is particularly an issue in non-
enlarged optic nerves (6), despite the application of special
techniques (7). A recent meta-analysis showed a sensitivity of
only 53% for optic nerve invasion (ONi), indicating a large
number of false-negative results (8).
Ocular ultrasonography (US) is a commonly used techni-
que for confirming irregular retinoblastoma masses inside
the eye. US can be performed without sedation and allows
for the accurate visualization of calcium inside the tumor (9).
Computed tomography is unnecessary for initial diagnostic
assessments because when coupled with MRI, US is currently
the safest and best method to diagnose retinoblastoma.DOI: 10.6061/clinics/2015(12)06
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Color Doppler imaging (CDI) is a US technique that
combines B-scan images with the velocity information
obtained from the Doppler shift of moving erythrocytes at
a known frequency; this method may be used to study the
small vessels of the orbit (10). Both the blood velocity and the
presence of vascular channels can be assessed, supplying
data for calculating indices to better understand the flow
patterns in retrobulbar blood vessels (11).
The purpose of this study was to use CDI to image retro-
bulbar blood vessels in monocular retinoblastoma before
enucleation, to compare blood velocities in the central retinal
artery (CRA) and central retinal vein (CRV) between a
tumor-containing eye and the contralateral normal eye and
to determine whether Doppler findings correlate with high-
risk clinical and pathological features of the enucleated eye
that could impact treatment and prognosis. A secondary
objective was to compare MRI, US and pathology measure-
ments of the tumor mass itself.
’ METHODS
This prospective study examined all monocular retino-
blastomas treated by enucleation without preoperative
adjunctive therapy in patients who presented to the Hospital
das Clínicas da Faculdade de Medicina da Universidade de
São Paulo between August 2010 and January 2014. This
study was approved by the institutional review board of the
hospital. The indication for primary enucleation was based
on the international classification of retinoblastoma (12-14),
including only the advanced stages (D and E) of the disease,
without a prognosis of vision recovery. The preoperative
workup comprised orbital and cranial MRI, orbital US, CDI
and ophthalmological examination with fundus drawing
under sedation. The high-risk clinical signs studied were
glaucoma, buphthalmos and proptosis.
US and CDI were performed using a Toshiba Aplio XG
and a Toshiba Aplio 500 (Tokyo, Japan) with a 16 MHz
transducer with presets for small parts. The power output
was 3-4 cm/sec and the mechanical index was set between
0.6 and 0.9; the power settings could not be reduced because
doing so would have affected the velocity detection relative
to the background noise artifact. The examination was
performed along the longitudinal and transverse axes, with
closed eyes and a large amount of US gel. Three tumor
diameters were assessed three times to determine the
arithmetic mean (longitudinal: L; transverse: T; and ante-
rior-posterior: AP) and the volume was manually calculated
based on these ultrasonographic means using the ellipsoid
formula (LTAP 0.52). Blood flow was assessed in the
CRA and CRV in both tumor-containing and normal eyes.
The CRA and CRV were identified together in the middle of
the optic nerve by using a US image and were measured
from the posterior scleral surface up to approximately 10 mm
behind this landmark using a Doppler angle between 30o and
60o (Figure 1). In a second approach that was only used for
retinoblastoma-containing eyes, two indices were calculated
and studied to evaluate high-risk clinical and pathological
findings. The first was the Pourcelot resistive index, which is
a measure of the peripheral vascular resistance of the CRA:
RIa=(PSV-EDV)/PSV, where PSV is the peak systolic velocity
and EDV is the end-diastolic velocity. The second was
Gosling’s pulsatility index for the CRV: PIv=(PSV-EDV)/
MFV), where MFV is the mean of the PSV and EDV. The
index calculation was performed automatically or manually
after fixing the PSV and EDV (Figure 2). We chose RIa and PIv
for the following reasons: the resistivity index for the CRA is
highly reliable because higher velocities provide better repro-
ducibility and the pulsatility index in the vein may provide an
indication of nerve invasion because venous blood flow is
influenced by the surrounding structures (11,15).
The enucleated eye was immersed for 24 hours in 10%
buffered neutral formalin. The surgical margin of the nerve was
cut and embedded face-down in paraffin for sectioning. The
globe was cut into three calottes, as follows: the main tumor
block, lined antero-posteriorly with the pupil and the optic
nerve; the temporal calotte; and the nasal calotte. The entire
globe was then embedded in paraffin and a minimum of six
serial sections (5 mm each) were cut at 100-150 mm intervals for
each calotte. If necessary, additional sections were cut through
the optic nerve head, the choroid and the optic nerve itself to
Figure 1 - Color Doppler image coupled with a 16 MHz ultrasonography image of a unilateral retinoblastoma. The central retinal artery
and central retinal vein were identified together in the middle of the optic nerve ultrasonography image and were then assessed from
the posterior scleral surface (A) up to approximately 10 mm behind this landmark (B). The flow above the x-axis shows a peaked wave
and represents the central retinal artery; the wave below this axis is more undulated and represents the central retinal vein. The spot
assessed is denoted by the two parallel lines crossed by an oblique line to indicate the Doppler angle, which is ideally between 30o and
60o. The blue cross and blue ‘A’ were added manually to the wave to measure the velocity, which may be quite high in the central
retinal artery of tumor-containing eyes (B).
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assess the degree of invasion (16). The pieces were then pro-
cessed for hematoxylin-eosin (HE) staining (Figure 3) and
classified according to the pTNM American Joint Committee
on Cancer (AJCC) classification (16). Retinoblastoma histo-
pathological analysis was based on the College of American
Pathologists (CAP) protocol (17), which involves examining the
size of the tumor, the grade of differentiation and the degrees of
necrosis and calcification. The antero-posterior axis plus both
calottes were examined for risk features such as tumor invasion
in the intraocular and extraocular tissues and optic nerve (ONi),
prelaminar optic nerve (PreONi), postlaminar optic nerve
(PosONi), surgical margin, anterior uveal, focal choroidal,
massive (or larger than 3 mm) choroidal (mCHi), scleral and
extrascleral invasion. Associated ocular findings secondary to
the presence of the tumor, including goniosynechiae and iris
neovascularization, were also analyzed.
The following experiments were performed. 1) The PSV
in the CRA and the maximum velocity in the CRV were
each compared between normal eyes (nlCRAv, nlCRVv) and
tumor-containing eyes (tuCRAv, tuCRVv) and the arith-
metic differences between the tumor-containing eye and the
normal eye of a given patient were compared for the CRA
and CRV. Clinical and pathological findings were also
correlated with tuCRAv and tuCRVv. 2) The largest diameter
in the pathology assessment and the largest diameters found
using MRI and US were compared. 3) Correlations of
tuCRAv and tuCRVv with the tumor volume (TUvol) deter-
mined by US and with MRI, US and pathology measure-
ments were analyzed. 4) Correlations between PIv and RIa
and all clinical and pathological features were analyzed.
Statistical tests were conducted using SPSS 17.0 for Win-
dows. The tests used (Student’s t-test, Pearson’s correlation,
the nonparametric Mann-Whitney U test and linear regres-
sion) are specified for all of the results shown.
’ RESULTS
In this period, we studied 18 cases that fulfilled the inclu-
sion criteria; these cases are summarized in Table 1. Four-
teen males (77.78%) and four females (22.22%) were
included. The right eye (OD) was affected in eight cases
(44.44%) and the left eye (OS) was affected in 10 (55.56%).
Nine eyes were in the D group (50%) and nine were in the
E group. Proptosis was present in two cases (11.11%) and
glaucoma was present in seven cases (41.18%), four of which
were complicated by buphthalmos (23.53%). Preoperative
MRI showed a median MRIm of 18.35 mm (range, 10.6 to
28 mm). The images raised suspicion of ONi, as indicated by
increased gadolinium uptake in four cases (22.22%), two
CNS alterations, one pineal cyst and one probable intraca-
nalicular ONi.
All CDI measurements were lost for one patient and the
normal data (nlCRAv and nlCRVv) were lost for another
three eyes due to a back-up failure in the machine. US
measurements were recorded for all 18 eyes, with a median
of 18.5 mm (range, 12.8-30 mm).
The pathology data showed a median diameter of 18.0 mm
(range, 10-28 mm), with moderate differentiation in seven
Figure 2 - (A) Color Doppler image of the right eye, which was the contralateral normal eye, showing a reduced peak velocity in the
central retinal artery and central retinal vein compared with that in tumor-containing eyes. (B) Color Doppler image of the left eye,
which was the tumor-containing eye of the same patient as shown in (A); the velocities (min., max. and average), resistivity index and
pulse index of the central retinal vein are displayed in the upper left-hand square. The wave boxes were inverted to allow automatic
calculations for the vein. The blue ‘A’ and cross were added manually.
Figure 3 - Pathology of an eye with enucleated retinoblastoma
showing optic nerve invasion. The hematoxylin-eosin photo-
micrograph shows the posterior displacement of the lamina
cribrosa by a compact blue tumor. Cords of tumor cells are inter-
mingled with the retrobulbar nerve tissue. The central retinal
vessels are surrounded by the invading tumor. Inset: higher-
power magnification showing details of the central retinal vein
surrounded by packed tumor cells.
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patients (38.89%), poor differentiation in 11 (61.11%) and
demonstrable calcification in 16 (88.89%). Choroid invasion
was demonstrated in 14 eyes (77.78%), but only six (33.33%)
showed mCHi. Anterior uveal invasion was present in only
one eye (5.56%). ONi was present in 11 eyes (61.11%),
prelaminar invasion in 11 eyes (61.11%) and postlaminar
invasion in four eyes (22.22%), with no compromised surgical
margin. No extrascleral invasion was found, whereas scleral
invasion was present in five eyes (27.78%). Iris neovascular-
ization was present in 17 eyes (94.44%) and goniosynechiae
was present in 15 eyes (83.33%).
Comparisons of the blood flow in normal eyes and
retinoblastoma-containing eyes are shown in Table 2. The
influence of tumor size and volume on the blood velocity is
shown in Table 3. The only significant correlation was the
positive correlation between tuCRAv and TUvol, as con-
firmed by the multivariate analysis (p=0.0331).
No difference was found in the tumor measurements by MRI
or US compared with the pathology assessment (p=0.675 and
p=0.375, respectively; Student’s t-test for matched pairs),
indicating that both methods were able to reliably determine
the real tumor size. However, the pathology assessment occasio-
nally underestimated the real size due to fixative artifacts.
Age, sex, tumor stage (D or E), clinical complications
(glaucoma, buphthalmos, proptosis), high-risk pathological
features (ONi, surgical margin, anterior uveal, choroidal,
mCHi, scleral and extrascleral invasion), tumor differentia-
tion and necrosis and secondary pathological findings (iris
neovascularization and goniosynechiae) did not modify the
blood velocities in the CRA or CRV, as indicated by analysis
using the parametric Mann-Whitney U test.
For only the tumor-containing eyes, RIa and PIv were also
compared with all variables using the parametric Mann-
Whitney U test. PIv was significantly lower in the male
patients than in the female patients (p=0.0270). RIa and PIv
were similar between eyes with clinical complications and
those without them; among the pathological high-risk features,
only ONi was correlated with a smaller PIv (p=0.0088),
Table 1 - Patient characteristics concerning demographics, clinical and pathological classifications, tumor measurements and Doppler
findings.
Patient Age/sex Eye/stage pTNM Pathm MRIm USm TUvol ONi mCHi tuCRAv tuCRVv nlCRAv nlCRVv RIa PIv
1 28/M OS/E pT3a 18 17 20.4 2.914 N Y 25.1 18.5 10 8.5 1 1.17
2 19/F OS/E pT1 17 20 19 2.25 N N 23 22.5 N/A N/A 0.76 1.18
3 8/M OD/E pT3a 20 19.7 17.3 N/A N Y N/A N/A N/A N/A N/A N/A
4 31/M OS/D pT2b 24 15.6 16.1 1.12 Y N 38.5 36 N/A N/A 0.84 0.45
5 23/M OS/E** pT3ay 16 22.2 20 2.99 N Y 22.1 9.5 10.6 7.5 0.8 0.94
6 37/F OS/D pT1 12 12 13 0.44 N N 23.3 10 15.3 N/A 0.78 1.27
7 12/F OD/E* pT2a 18 21 12.8 0.49 N N 13 8.2 4.8 4 1 0.9
8 36/F OS/E pT3a 28 28 26 1.65 Y Y 13.1 10.6 6.5 3.2 0.78 1.2
9 21/M OD/E pT3a 20 25 25.7 1.1 Y N 18.9 11.2 7.6 3.5 0.83 0.53
10 48/M OD/D pT3a 15 21 30 2.66 Y N 45 10 8.5 5.5 1 0.85
11 66/M OD/D pT3a 20 17 16.2 1.872 N Y 29 11.4 N/A N/A 0.88 1.14
12 48/M OS/D pT2a 16 14 20 2.2 Y N 23 26 7 6.1 1 0.9
13 16/M OS/D pT2b 13 10.6 13.5 0.32 Y N 30 14 8.2 7.1 0.87 0.9
14 30/M OS/D pT2b 20 15.9 18 2.09 Y N 46 28.5 36 10 0.89 0.8
15 18/M OS/D pT2b 16 16 16.8 1.52 Y N 13.4 8.5 4.7 3.2 0.6 0.67
16 36/M OD/E** pT3a 10 24.4 23.8 5.56 Y Y 44.5 14.4 15 6.9 0.94 0.93
17 20/M OD/E pT3b 20 21 23.8 4.5 Y Y 39.7 22 11 7.8 0.94 0.69
18 72/M OD/D pT2b 20 12.3 14.1 0.94 Y N 19.4 10.9 13.6 10.9 0.7 0.38
Age in months; sex: M=male, F=female; stages ‘D’ and ‘E’ from the international classification (12); pTNM=AJCC pathological classification (16); Pathm,
USm, MRIm=tumor size in millimeters, as measured from a pathological section, by ultrasonography and by magnetic resonance imaging, respectively;
TUvol=tumor volume in cm3; ONi=optic nerve invasion; mCHi=massive choroid invasion; Y=presence; N=absence; tuCRAv and nlCRAv=peak blood
velocities in the central retinal artery in tumorous and normal eyes, respectively; tuCRVv and nlCRVv=peak blood velocities in the central retinal vein
in tumorous and normal eyes, respectively (velocity in cm/sec); RIa=resistivity index in the central retinal artery; PIv=pulse index in the central retinal vein;
*=phthisis; **=proptosis; y=initially presenting with only calcification.
Table 2 - Blood velocities in the central retinal artery and
centralretinal vein in tumorous (tuCRAv and tuCRVv) and normal
(nlCRAv and nlCRVv) eyes.
Variable n Mean MD Median Min Max p*
tuCRAv 14 26.89 12.14 23.15 13.00 46.00 o0.001
nlCRAv 14 11.34 7.87 9.25 4.70 36.00
tuCRVv 13 14.79 6.83 11.20 8.20 28.50 o0.001
nlCRVv 13 6.48 2.53 6.90 320 10.90
aCRAv 13 16.13 9.93 11.50 5.80 36.50 0.024
aCRVv 13 8.32 5.98 7.40 0.00 19.90
The blood velocity was higher in tumorous eyes than in normal eyes
(highly significant difference). When considering the arithmetic
differences between the tumorous and the normal eyes for both the
artery (aCRAv) and the vein (aCRVv), the P-value was also significant,
indicating that tuCRAv is more influenced by the tumor than is tuCRVv.
(*) Student’s t-test for matched pairs.
Table 3 - Correlations of the tumor size, as measured by
ultrasound (USm), MRI (MRIm), and pathological sectioning
(Pathm), and the tumor volume (TUvol) with the peak blood
velocities in the central retinal artery (tuCRAv) and central retinal
vein (tuCRVv).
Age Pathm MRIm USm TUvol
n 17 16 17 17 17
tuCRAv r (*) 0.125 -0.22 -0.05 0.302 0.535
p 0.633 0.406 0.844 0.24 0.027
n 13 13 13 13 13
tuCRVv r (*) 0.087 0.02 -0.33 0.005 0.306
p 0.777 0.948 0.275 0.987 0.31
A positive correlation was found between TUvol and tuCRAv. The larger
the volume of the tumor was, the faster the blood flow in the central
retinal artery was. (*) Pearson’s correlation coefficient, n=number of
samples studied.
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indicating that the venous pulse index was reduced when
the optic nerve was invaded by the tumor (Table 4). The
difference persisted when considering PreONi (p=0.0088)
but not PosONi (p=0.2563). ONi did not modify the arterial
index RIa (p=0.9596).
’ DISCUSSION
Retinoblastoma is a highly malignant retinal neoplasia that
tends to invade other intraocular structures and the optic
nerve and, with progressive growth, to become extraocular.
In recent years, due to educational programs, retinoblastoma
has been diagnosed earlier, and retinoblastoma treatment has
aimed to preserve the eye and the patient’s vision. Therefore,
primary enucleation is indicated much less frequently than in
the past and is only recommended for advanced stages
because of the association with a higher risk of metastasis
(14). For this reason, enucleation is the treatment of choice
when there is little or no potential for vision recovery,
especially if ONi is suspected. Important histopathological
risk factors for local recurrence and metastasis include tumor
invasion of the surgical margin of the optic nerve, post-
laminar ONi, extrascleral invasion, scleral invasion and
massive choroidal invasion (2,18-20).
Imaging the eye prior to enucleation to predict tumor
prognosis is a well-recognized technique. Imaging studies of
the optic nerve, orbit and CNS using MRI may be important
for both conservative treatment and enucleation of the eye (3);
however, MRI findings in patients with normal-sized optic
nerves have limited usefulness in preoperatively predicting the
presence of ONi in retinoblastomas (6). According to a recent
meta-analysis of radiological imaging of retinoblastomas that
considered 591 eyes examined byMRI in 14 studies and found a
sensitivity of 59% for postlaminar ONi, 74% for choroidal
invasion and 88% for scleral invasion, MRI is an important
diagnostic tool for determining the local tumor extent in
advanced retinoblastoma. However, the diagnostic accuracy
has room for improvement, especially regarding sensitivity (8).
Assessing the blood flow in intraocular tumors using CDI
is not a new concept (21), but few prior publications are
available. In a previous study, we analyzed vascularization
inside a retinoblastoma itself by CDI as a follow-up to the
conservative treatment of bilateral disease. Our findings
showed that the blood vessels inside the tumor mass
disappeared on the color Doppler image, indicating a
response to the therapeutic approach, before total involution
of the tumor. For this reason, this technique cannot replace
fundus examination to evaluate the treatment of intraocular
retinoblastoma but could be helpful for diagnosing, espe-
cially in the presence of cloudy ocular media and for
evaluating the treatment response (unpublished data; Bona-
nomi MTBC, Saito OC, Tanaka T. Retinoblastoma assessment
by Doppler sonography - a follow-up study. Poster presented
at the Annual ARVO Meeting, May 2, 2011; Fort Lauderdale,
Florida).
In the present study, we imaged retrobulbar vessels by
CDI, compared retinoblastoma-containing eyes with the
contralateral normal eyes and studied the relationships
between blood velocities and demographics, clinical findings
and tumor sizes and histopathological complications. We
faced several difficulties in performing the examinations and
analyzing the images. Even for CDI performed under
sedation, obtaining at least three similar pulse waves that
include calcium and its shadows for a tumor-containing eye
can be challenging. Frequently, the limits of the sclera and
optic nerve shadow are imprecise and the images must
therefore be taken farther back in the optic nerve. Care must
be taken to avoid placing the Doppler cursor more than
10 mm from the sclera because anatomically, the ophthalmic
artery begins at 15 mm. If one overcomes this initial technical
barrier, the measurements can be collected automatically. The
peak blood velocities in the CRA and CRV were significantly
higher in the tumor-containing eyes than in the contralateral
normal eyes (Table 2), indicating a hemodynamic change in
the retrobulbar vessels caused by the presence of a large
tumor. The difference in the velocities between the normal
eye and the tumor-containing eye of the same patient were
larger in the CRA than in the CRV (Table 2), demonstrating
that the tumor has a greater influence on tuCRAv than on
tuCRVv.
In retinoblastoma-containing eyes, the next challenge was
to calculate the volume in a diffuse infiltrative tumor or in
multiple non-confluent tumors. In both cases, the sum of the
volumes, calculated segment by segment, was considered as
TUvol. This point is important because TUvol was the
only size variable related to a higher velocity in the CRA
Table 4 - Correlation of optic nerve invasion by the tumor with the resistivity index of the central retinal artery and the pulse index of
the central retinal vein.
ONi PreONi PosONi
N Y N Y N Y
n 6 11 6 11 13 4
PIv Mean/std 1.10/0.15 0.75/0.24 1.10/0.15 0.75/0.24 0.92/0.28 0.75/0.18
Min/max 0.90/1.27 0.38/1.20 0.90/1.27 0.38/1.20 0.38/1.27 0.53/0.93
Median 1.16 0.80 1.16 0.80 0.90 0.77
P25/P75 0.94/1.18 0.53/0.90 0.94/1.18 0.53/0.90 0.80/1.17 0.61/0.89
p* 0.009 0.009 0.256
n 6 11 6 11 13 4
RIa Mean/std 0.87/0.11 0.85/0.12 0.87/0.11 0.85/0.12 0.84/0.12 0.93/0.07
Min/max 0.76/1.00 0.60/1.00 0.76/1.00 0.60/1.00 0.60/1.00 0.83/1.00
Median 0.84 0.87 0.84 0.87 0.84 0.94
P25/P75 0.78/1.00 0.78/0.94 0.78/1.00 0.78/0.94 0.78/0.89 0.89/0.97
p* 0.960 0.960 0.190
Optic nerve invasion was correlated with a smaller PIv; this difference persisted when considering PreONi but did not when considering PosONi.
PIv=pulsatility index of the central retinal vein; RIa=resistivity index of the central retinal artery; N=without invasion; Y=with invasion; ONi=optic nerve
invasion; PreONi=prelaminar optic nerve invasion; PosONi=postlaminar optic nerve invasion. (*) non-parametric Mann-Whitney U test.
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(Table 3). Thus, according to this result, tumor-containing
eyes presented higher peak velocities in the CRA and CRV.
The difference was higher for the artery and the increase in
tuCRAv was positively correlated with TUvol.
However, when tumor-containing eyes were considered
exclusively, tuCRAv and tuCRVv were not influenced by age,
sex, tumor stage, clinical complications (e.g., buphthalmos and
proptosis) or any high-risk pathological features. Thus, accord-
ing to these findings, the presence of a tumor alone, especially a
large tumor, can trigger the sequence of events that causes
elevations in the blood flow velocities in the retrobulbar CRA
and CRV. These elevations are similar to events observed in
tumors elsewhere in the body (22). Retrobulbar blood flow has
been well studied in glaucoma and retinal disease. In open-
angle glaucoma, there is a significant lowering of the PSV and
EDV in the CRA with an increase in RIa and these alterations
are reversible by lowering the intraocular pressure (23). As
complications of retinoblastoma, glaucoma and buphthalmos
did not lower tuCRAv in the current study. The presence of the
tumor itself appears to promote the increases in blood velocities
that are then unaffected by the superimposed pathology.
RIa was not correlated with any specific patient or tumor
characteristic. A significantly lower pulse index in the CRV was
found in males and in patients with ONi. PIv is considered to be
the most sensitive parameter for differentiating abnormal
waveforms because it accounts for the mean velocity and
because its denominator never reaches zero (11). Could tumor
cell infiltration have the same effect on flow, modifying PIv, as
described, in association with senile alterations of the arterial
wall (15)? This question should be answerable if a cut-off value
is established to identify ONi. Because the difference in PIv
between eyes with ONi and those without ONi was highly
significant (p=0.009) in the present study, the number of cases
needed to identify a cut-off value should not be large.
Unfortunately, we had only six cases without Oni; therefore,
we must postpone this investigation until future studies.
Fortunately, as stated before, primary enucleation is seldom
indicated; therefore, obtaining a sufficient number in both
groups will take time. Another unexplained finding is the lower
pulse index that was observed for males.
In conclusion, the peak blood velocities in the CRA and
CRVare higher in tumor-containing eyes than in normal eyes
(po0.001). The arithmetic differences between the velocities
in the tumor-containing and normal eyes are significant for
both the CRA and the CRV (p=0.024), indicating that
alterations are significantly higher in the CRA than in the
CRV. TUvol, based on three US measurements, is related to a
higher peak velocity in the CRA (p=0.0331). The resistivity
index of the CRA is not related to the high-risk features of
tumors, but the pulse index of the CRV is related to male sex
(p=0.017) and ONi by the tumor (p=0.008).
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